DOSIsoft Creates a US Branch in Florida
- September 22, 2016
DOSIsoft Americas is located within the University of Miami’s Health District, the second largest Health District in the USA and is managed by Mr. Jean-Elie KAFROUNI, Head of US Operations. It will specifically serve the US market as well as support the whole North, Central and South America requirements.
Marc Uszynski is Nominated as DOSIsoft’s Chief Executive Officer
- September 15, 2016
Passionated by high-tech, Marc Uszynski takes up a new challenge by joining DOSIsoft, company with a strong growth potential offering software solutions in radiotherapy and molecular imaging.
PLANET® Dose Becomes the 1st Dosimetry Software for SIRT to Receive CE Marking
- March 29, 2016
DOSIsoft SA, leading software editor specialized in RT Planning, Patient QA and Molecular Imaging, is proud to announce the CE marking (European Conformity) of PLANET® Dose, solution for 90Y-microspheres Selective Internal Radiation Therapy (SIRT) dosimetry, issued on March 22nd, 2016.
EPIGRAY®, EPID-Based Transit Dosimetry Software Receives a Licence issued by Health Canada
- February 24, 2016
DOSIsoft SA, french software leader specialized in Radiotherapy and Medical Imaging, is pleased to announce that EPIgray®, EPID-based transit dosimetry solution, has received a Medical Device Licence from Health Canada, on the 2nd of February, 2016 and is now available for sale on the Canadian market.
DOSIsoft Becomes « CHAMPIONS 2015 » & « INNOVATIVE COMPANY » of the Year
- October 23, 2015
DOSIsoft has the honor of being among the “Champions 2015” of Systematic Paris-Region Competitiveness Cluster, dedicated to software and digital. It is also labelled “Innovative Company of the Clusters” (EIP), label of quality of application files submitted to investors.
DOSIsoft Announces its International Development in China
- September 10, 2015
After the first successful installation of EPIgray® at Hebei Tumor Hospital (Shijiazhuang, China) in March, the centers of 301 Military Hospital and Cancer Hospital Chinese Academy of Medical Science (CAMS) in Beijing as well as the First Hospital of Chinese Medical University in Shenyang are evaluating EPIgray® – EPID-based in vivo dose monitoring system.